Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.5M | $-4.8M | $12.3M | $5.8M | $2.1M | $1.4M | $-5.6M | $-360.0K |
| Depreciation & Amortization | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.5M | $2.5M |
| Depreciation | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $200.0K |
| Amortization | $2.4M | $2.4M | $800.0K | $2.4M | $2.4M | $2.4M | $2.0M | $2.0M |
| Stock-Based Compensation | $2.1M | $2.4M | $2.4M | $2.5M | $2.4M | $2.8M | $2.6M | $2.8M |
| Net Cash from Operating Activities | $1.0M | $11.2M | $10.5M | $10.6M | $3.3M | $2.6M | $7.7M | $17.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $20.0K | $0 | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $703.0K | $-19.1M | $-8.2M | $11.2M | $-4.7M | $-17.5M | $-11.9M | $8.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-11.3M | $0 | $0 | $0 | $0 | $0 | $2.4M | $-53.0K |
| Net Change in Cash | $-9.6M | $-7.8M | $2.3M | $21.8M | $-1.4M | $-14.8M | $-1.8M | $25.2M |
| Free Cash Flow | $1.0M | $11.2M | — | — | — | — | — | — |